University of Colorado, Denver

The organizations in the consortium will identify, characterize, and catalog human biological molecules affected by physical activity in volunteer biosamples.

Vanderbilt University, the University of Colorado at Denver, Partners HealthCare, and the Montreal Heart Institute will use Illumina technology to analyze their biobank samples.

The new findings point towards creating different treatment strategies for combating the disease in old and young patient groups. 

The partners will evaluate whether circulating tumor DNA profiling has use for monitoring treatment response and relapse in melanoma patients. 

Tech Transfer Tidbits

Premium

Kauffman Foundation, MIT, BioAMPS, University of Colorado, Endo Pharma, Harvard, Galapagos, Flanders Institute of Biotechnology, and more …

Funding from the National Institutes of Health for all proteomics-related research shrank by almost 3 percent in fiscal 2008, according to an analysis of NIH data by ProteoMonitor.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.